Talking with C. Michael Gibson, David Austin reviews the phase III trial of enalapril for anthracycline-induced cardiotoxicity in lymphoma and breast cancer patients.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
